Advanced Illness and Frailty Exclusions Allowed for HEDIS® Star Measures

  • February 3, 2022

    In October 2021, the National Committee for Quality Assurance (NCQA) released value set changes for the following Healthcare Effectiveness Data and Information Set (HEDIS®) Quality measures:

    New and returning measures that are expected to be included in star ratings:

    • Follow-up after emergency department visit for people with multiple high-risk chronic conditions (FMC)
      • Patients age 18 and older who have multiple high-risk chronic conditions and who had a follow-up visit within seven days of an emergency department visit.
    • Plan all-cause readmissions (PCR)
      • The number of acute inpatient and observation stays for patients age 18 and older that were followed by an unplanned acute readmission for any diagnosis within 30 days.
    • Transitions of care (TRC) 
      • Patients who had an acute or non-acute inpatient discharge during the measurement year and who had each of the following:
        • Notification of inpatient admission
        • Receipt of discharge information
        • Patient engagement after inpatient discharge
        • Medication reconciliation post-discharge
    • The comprehensive diabetes care (CDC) measures have been separated as follows: 
    • Hemoglobin A1c control for patients with diabetes (HBD)
      • Patients ages 18–75 with a diagnosis of diabetes (Type 1 or Type 2) whose HbA1c was adequately controlled (≤9%) as of December 31 of the measurement year
    • Kidney health evaluation for patients with diabetes (KED)
      • Patients ages 18–85 with a diagnosis of diabetes (Type 1 or Type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ration (uACR), during the measurement year

    Learn more about these measures –including who is included in the measure, exclusions, and tips –by clicking on the links provided above.

    For more information and/or questions regarding this article, email ProviderClinicalConsulting@Premera.com.

    HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

  •    Email this article